Liaoning, China

Xin Fu

This inventor holds 1 USPTO granted patent. Top assignee: Dalian University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Fu. Retrieved from https://idiyas.com/inventor/xin-fu-slt8xz44

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xin Fu

Introduction

Xin Fu is a notable inventor based in Liaoning, China. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His innovative methods have the potential to advance various applications in medicine and research.

Latest Patents

Xin Fu holds a patent for a "Method of producing a sialylated N-glycosylated recombinant protein in periplasm of a recombinant." This patent describes a method for producing a sialylated N-glycosylated recombinant protein in the periplasm of a recombinant strain W3110ΔnanKETA::Kan. The sialylated oligosaccharide chain involved in this process is Neu5Ac-α-2,6-Gal-β-1,4-GlcNAc-β-1,3-Gal-β-1,3-GlcNAc. This innovation is crucial for enhancing the functionality of recombinant proteins.

Career Highlights

Xin Fu is affiliated with Dalian University, where he conducts research and develops his innovative methods. His work has garnered attention in the scientific community, contributing to advancements in biotechnology.

Collaborations

Xin Fu collaborates with esteemed colleagues, including Xuejun Hu and Yao Ruan. Their combined expertise fosters a productive research environment, leading to further innovations in their field.

Conclusion

Xin Fu's contributions to biotechnology through his innovative methods and collaborations highlight the importance of research in advancing scientific knowledge. His work continues to inspire future developments in the production of recombinant proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…